Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
Attralus, Inc
Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis
August 12, 2026
Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis
June 4, 2026